Top Markets
Coin of the day
CARGO Therapeutics, Inc. Common Stock CARGO Therapeutics, Inc. Common Stock

CARGO Therapeutics, Inc. Common Stock

CRGX
Rang in Aktien #18093
CARGO Therapeutics, Inc. is a clinical-stage biopharmaceutical company... CARGO Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to pioneering innovative chimeric antigen receptor (CAR) T-cell therapies for patients battling cancer. Its primary therapeutic candidate is CRG-022, an autologous CD22 CAR T-cell product. This therapy is specifically engineered to counteract mechanisms of resistance in B-cell malignancies by targeting CD22, a distinct tumor antigen prevalent in these conditions. The company's pipeline also includes CRG-023, a novel tri-specific CAR T product candidate designed to engage tumor cells through three different B-cell antigen targets. Formerly known as Syncopation Life Sciences, Inc., the company adopted its current name, CARGO Therapeutics, Inc., in September 2022. Established in 2019, CARGO Therapeutics is headquartered in San Mateo, California.
Aktienkurs
$4.47
Zuletzt synchronisiert: 2025-08-20
Marktkapitalisierung
$213.06M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel CARGO Therapeutics, Inc. Common Stock (CRGX)

Kategorie

Kursverlauf für CARGO Therapeutics, Inc. Common Stock (CRGX)
Höchster Schlusskurs: $4.48 am 2025-08-01

Niedrigster Schlusskurs: $14.85 am 2023-11-01
Kursverlauf der Aktie von CARGO Therapeutics, Inc. Common Stock von 2023 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2025 -71.01%
2024 -16.24%
2023 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$556.43 40.29%
US
$1.05K 45.39%
NL
$152.82 535.43%
US
$122.66 -9.24%
AU
$757.71 6.76%
CH